Skip to main content
Top
Published in: BMC Gastroenterology 1/2023

Open Access 01-12-2023 | Wound Infection | Research

Effectiveness of betadine-coating gastrostomy tube to reduce peristomal infection after percutaneous endoscopic gastrostomy: a randomized controlled trial

Authors: Yu-Jen Chen, Ming-Chih Hou, Tsung-Chieh Yang, Pei-Chang Lee, Yen-Po Wang, Yi-Hsiang Huang, Fa-Yauh Lee

Published in: BMC Gastroenterology | Issue 1/2023

Login to get access

Abstract

Background

Peristomal wound infection is a common complication in patients receiving percutaneous endoscopic gastrostomy (PEG). The main reason for peristomal infection might be the oral microbes coating the gastrostomy tube during implantation. Povidone-iodine solution can be applied for skin and oral decontamination. We designed a randomized controlled trial to test the effectiveness of a Betadine® (povidone-iodine) coated gastrostomy tube to reduce peristomal infection after percutaneous endoscopic gastrostomy.

Methods

A total of 50 patients were randomized to Betadine and control groups (25 patients in each group) from April 2014 to August 2021 at a tertiary medical center. All patients received the pull method for PEG implantation using a 24-french gastrostomy tube. The primary endpoint was peristomal wound infection rate 2 weeks after the procedure.

Results

Changes in Neutrophil/Lymphocyte ratio (N/L ratio) and C-Reative protein (Delta CRP) at 24 h after PEG were higher in the control group than in the Betadine group (N/L ratio, 3.1 vs. 1.2, p = 0.047; CRP, 2.68 vs.1.16, p = 0.009). The two groups did not differ in post-PEG fever, peristomal infection, pneumonia, or all-cause infection. Delta CRP could predict peristomal infection and all-cause infection within 2 weeks (AUROC 0.712 vs. 0.748; p = 0.039 vs. 0.008). The best cut-off-point of Delta CRP for the diagnosis of peristomal wound infection was 3 mg/dl.

Conclusion

The betadine coating gastrostomy tube method could not reduce peristomal infection after percutaneous endoscopic gastrostomy. CRP elevation of less than 3 mg/dl may be used to exclude the potential peristomal wound infection.
Appendix
Available only for authorised users
Literature
1.
go back to reference Gauderer MW, Ponsky JL, Izant RJ Jr. Gastrostomy without laparotomy: a percutaneous endoscopic technique. J Pediatr Surg. 1980;15:872–5.CrossRefPubMed Gauderer MW, Ponsky JL, Izant RJ Jr. Gastrostomy without laparotomy: a percutaneous endoscopic technique. J Pediatr Surg. 1980;15:872–5.CrossRefPubMed
2.
go back to reference Van Dyck E, Macken EJ, Roth B, Pelckmans PA, Moreels TG. Safety of pull-type and introducer percutaneous endoscopic gastrostomy tubes in oncology patients: a retrospective analysis. BMC Gastroenterol. 2011;11:23.CrossRefPubMedPubMedCentral Van Dyck E, Macken EJ, Roth B, Pelckmans PA, Moreels TG. Safety of pull-type and introducer percutaneous endoscopic gastrostomy tubes in oncology patients: a retrospective analysis. BMC Gastroenterol. 2011;11:23.CrossRefPubMedPubMedCentral
3.
go back to reference Teich N, Selig L, Liese S, Schiefke F, Hemprich A, Mössner J, Schiefke I. Usage characteristics and adverse event rates of the direct puncture and pull techniques for percutaneous endoscopic gastrostomy in patients with malignant tumors of the upper aerodigestive tract. Endosc Int Open. 2018;6:E29–E35.CrossRefPubMedPubMedCentral Teich N, Selig L, Liese S, Schiefke F, Hemprich A, Mössner J, Schiefke I. Usage characteristics and adverse event rates ​of the direct puncture and pull techniques for percutaneous endoscopic gastrostomy in patients with malignant tumors of the upper aerodigestive tract. Endosc Int Open. 2018;6:E29–E35.CrossRefPubMedPubMedCentral
5.
go back to reference Wollman B, D’Agostino HB, Walus-Wigle JR, Easter DW, Beale A. Radiologic, endoscopic, and surgical gastrostomy: an institutional evaluation and meta-analysis of the literature. Radiology. 1995;197:699–704.CrossRefPubMed Wollman B, D’Agostino HB, Walus-Wigle JR, Easter DW, Beale A. Radiologic, endoscopic, and surgical gastrostomy: an institutional evaluation and meta-analysis of the literature. Radiology. 1995;197:699–704.CrossRefPubMed
6.
go back to reference Mamel JJ. Percutaneous endoscopic gastrostomy. Am J Gastroenterol. 1989;84:703–10.PubMed Mamel JJ. Percutaneous endoscopic gastrostomy. Am J Gastroenterol. 1989;84:703–10.PubMed
7.
go back to reference Rahnemai-Azar AA, Rahnemaiazar AA, Naghshizadian R, Kurtz A, Farkas DT. Percutaneous endoscopic gastrostomy: indications, technique, complications and management. World J Gastroenterol. 2014;20:7739–51.CrossRefPubMedPubMedCentral Rahnemai-Azar AA, Rahnemaiazar AA, Naghshizadian R, Kurtz A, Farkas DT. Percutaneous endoscopic gastrostomy: indications, technique, complications and management. World J Gastroenterol. 2014;20:7739–51.CrossRefPubMedPubMedCentral
8.
go back to reference Gottlieb K, Iber FL, Livak A, Leya J, Mobarhan S. Oral Candida colonizes the stomach and gastrostomy feeding tubes. JPEN J Parenter Enteral Nutr. 1994;18:264–7.CrossRefPubMed Gottlieb K, Iber FL, Livak A, Leya J, Mobarhan S. Oral Candida colonizes the stomach and gastrostomy feeding tubes. JPEN J Parenter Enteral Nutr. 1994;18:264–7.CrossRefPubMed
9.
go back to reference Lipp A, Lusardi G. Systemic antimicrobial prophylaxis for percutaneous endoscopic gastrostomy. Cochrane Database Syst Rev. 2013; 2013 Lipp A, Lusardi G. Systemic antimicrobial prophylaxis for percutaneous endoscopic gastrostomy. Cochrane Database Syst Rev. 2013; 2013
10.
go back to reference Maetani I, Yasuda M, Seike M, Ikeda M, Tada T, Ukita T, Sakai Y. Efficacy of an overtube for reducing the risk of peristomal infection after PEG placement: a prospective, randomized comparison study. Gastrointest Endosc. 2005;61:522–7.CrossRefPubMed Maetani I, Yasuda M, Seike M, Ikeda M, Tada T, Ukita T, Sakai Y. Efficacy of an overtube for reducing the risk of peristomal infection after PEG placement: a prospective, randomized comparison study. Gastrointest Endosc. 2005;61:522–7.CrossRefPubMed
12.
go back to reference Gardner DF, Mars DR, Thomas RG, Bumrungsup C, Misbin RI. Iodine retention and thyroid dysfunction in patients on hemodialysis and continuous ambulatory peritoneal dialysis. Am J Kidney Dis. 1986;7:471–6.CrossRefPubMed Gardner DF, Mars DR, Thomas RG, Bumrungsup C, Misbin RI. Iodine retention and thyroid dysfunction in patients on hemodialysis and continuous ambulatory peritoneal dialysis. Am J Kidney Dis. 1986;7:471–6.CrossRefPubMed
13.
go back to reference Kim CS, Kim SS, Bae EH, Ma SK, Kim SW. Acute kidney injury due to povidone-iodine ingestion: a case report. Med (Baltim). 2017;96:e8879.CrossRef Kim CS, Kim SS, Bae EH, Ma SK, Kim SW. Acute kidney injury due to povidone-iodine ingestion: a case report. Med (Baltim). 2017;96:e8879.CrossRef
14.
go back to reference Scopp IW, Orvieto LD. Gingival degerming by povidone-iodine irrigation: bacteremia reduction in extraction procedures. J Am Dent Assoc. 1971;83:1294–6.CrossRefPubMed Scopp IW, Orvieto LD. Gingival degerming by povidone-iodine irrigation: bacteremia reduction in extraction procedures. J Am Dent Assoc. 1971;83:1294–6.CrossRefPubMed
15.
go back to reference Brenman HS, Randall E. Local degerming with povidone-iodine, II. Prior to gingivectomy. J Periodontol. 1974;45:870–2.CrossRefPubMed Brenman HS, Randall E. Local degerming with povidone-iodine, II. Prior to gingivectomy. J Periodontol. 1974;45:870–2.CrossRefPubMed
16.
go back to reference Jain NK, Larson DE, Schroeder KW, Burton DD, Cannon KP, Thompson RL, DiMagno EP. Antibiotic prophylaxis for percutaneous endoscopic gastrostomy. A prospective, randomized, double-blind clinical trial. Ann Intern Med. 1987;107:824–8.CrossRefPubMed Jain NK, Larson DE, Schroeder KW, Burton DD, Cannon KP, Thompson RL, DiMagno EP. Antibiotic prophylaxis for percutaneous endoscopic gastrostomy. A prospective, randomized, double-blind clinical trial. Ann Intern Med. 1987;107:824–8.CrossRefPubMed
17.
go back to reference Horiuchi A, Nakayama Y, Kajiyama M, Fujii H, Tanaka N. Nasopharyngeal decolonization of methicillin-resistant Staphylococcus aureus can reduce PEG peristomal wound infection. Am J Gastroenterol. 2006;101:274–7.CrossRefPubMed Horiuchi A, Nakayama Y, Kajiyama M, Fujii H, Tanaka N. Nasopharyngeal decolonization of methicillin-resistant Staphylococcus aureus can reduce PEG peristomal wound infection. Am J Gastroenterol. 2006;101:274–7.CrossRefPubMed
18.
go back to reference Beukelman CJ, van den Berg AJ, Hoekstra MJ. Anti-inflammatory properties of a liposomal hydrogel with povidone-iodine (Repithel) for wound healing in vitro. Burns. 2008;34:845–55.CrossRefPubMed Beukelman CJ, van den Berg AJ, Hoekstra MJ. Anti-inflammatory properties of a liposomal hydrogel with povidone-iodine (Repithel) for wound healing in vitro. Burns. 2008;34:845–55.CrossRefPubMed
19.
go back to reference König B, Reimer K, Fleischer W. Effects of Betaisodona on parameters of host defense. Dermatology. 1997;195(Suppl 2):42–8.CrossRefPubMed König B, Reimer K, Fleischer W. Effects of Betaisodona on parameters of host defense. Dermatology. 1997;195(Suppl 2):42–8.CrossRefPubMed
20.
go back to reference Póvoa P. C-reactive protein: a valuable marker of sepsis. Intensive Care Med. 2002;283:235–43.CrossRef Póvoa P. C-reactive protein: a valuable marker of sepsis. Intensive Care Med. 2002;283:235–43.CrossRef
21.
go back to reference Matson A, Soni N, Sheldon J. C-reactive protein as a diagnostic test of sepsis in the critically ill. Anaesth Intensive Care. 1991;19:182–6.CrossRefPubMed Matson A, Soni N, Sheldon J. C-reactive protein as a diagnostic test of sepsis in the critically ill. Anaesth Intensive Care. 1991;19:182–6.CrossRefPubMed
22.
go back to reference Yentis SM, Soni N, Sheldon J. C-reactive protein as an indicator of resolution of sepsis in the intensive care unit. Intensive Care Med. 1995;21:602–5.CrossRefPubMed Yentis SM, Soni N, Sheldon J. C-reactive protein as an indicator of resolution of sepsis in the intensive care unit. Intensive Care Med. 1995;21:602–5.CrossRefPubMed
23.
go back to reference Janet F, Starkey PA, Jefferson, Donald F. Kirby. Taking care of Percutaneous Endoscopic Gastrostomy. Am J Nurs. 1988;88:42–5. Janet F, Starkey PA, Jefferson, Donald F. Kirby. Taking care of Percutaneous Endoscopic Gastrostomy. Am J Nurs. 1988;88:42–5.
Metadata
Title
Effectiveness of betadine-coating gastrostomy tube to reduce peristomal infection after percutaneous endoscopic gastrostomy: a randomized controlled trial
Authors
Yu-Jen Chen
Ming-Chih Hou
Tsung-Chieh Yang
Pei-Chang Lee
Yen-Po Wang
Yi-Hsiang Huang
Fa-Yauh Lee
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2023
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-023-02702-w

Other articles of this Issue 1/2023

BMC Gastroenterology 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine